Occurrence of Non-Hodgkin's Lymphoma after Therapy for Hodgkin's Disease

New England Journal of Medicine

Volumn 300, Issue 9, 1979, Pages 452-458

  Krikorian, John G ^a   Burke, Jerome S ^a   Rosenberg, Saul A ^a   Kaplan, Henry S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYTOSTATIC AGENT; DOXORUBICIN; MELPHALAN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADVERSE DRUG REACTION; CANCER CHEMOTHERAPY; CARCINOGENESIS; CASE REPORT; HODGKIN DISEASE; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOMA; NONHODGKIN LYMPHOMA; RADIOTHERAPY; THERAPY;

EID: 0018415536     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197903013000902     Document Type: Article

References (39)

1. Moertel CG, Hagedorn AB: Leukemia or lymphoma and coexistent primary malignant lesions: a review of the literature and a study of 120 cases. Blood 12: 788–803, 1957
2. Razis DV, Diamond HD, Craver LF: Hodgkin's disease associated with other malignant tumors and certain non-neoplastic diseases. Am J Med Sci 238: 327–335, 1959
3. Berg JW: The incidence of multiple primary cancers. I. Development of further cancers in patients with lymphomas, leukemias, and myeloma. J Natl Cancer Inst 38: 741–752, 1967
4. Whitelaw DM: Multiple primary carcinomas associated with Hodgkin's disease. Can Med Assoc J 99: 291–294, 1968
5. Canellos GP, DeVita VT, Arseneau JC, et al: Second malignancies complicating Hodgkin's disease in remission. Lancet 1: 947–949, 1975
6. Toland DM, Coltman CA Jr: Second malignancies complicating Hodgkin's disease. Blood 46: 1013, 1975
7. Brody RS, Schottenfeld D, Reid A: Multiple primary cancer risk after therapy for Hodgkin's disease. Cancer 40: 1917–1926, 1977
8. Arseneau JC, Canellos GP, Johnson R, et al: Risk of new cancer in patients with Hodgkin's disease. Cancer 40: 1912–1916, 1977
9. Cadman EC, Capizzi RL, Bertino JR: Acute non-lymphocytic leukemia: a delayed complication of Hodgkin's disease therapy: analysis of 109 cases. Cancer 40: 1280–1296, 1977
10. Coleman CN, Williams CJ, Flint A, et al: Hematologic neoplasia in patients treated for Hodgkin's disease. N Engl J Med 297: 1249–1252, 1977
11. Reimer RR, Hoover R, Fraumeni JF Jr, et al: Acute leukemia after alkylating-agent therapy of ovarian cancer. N Engl J Med 297: 177–181, 1977
12. Kim H, Dorfman RF: Morphological studies of 84 untreated patients subjected to laparotomy for the staging of non-Hodgkin's lymphomas. Cancer 33: 657–674, 1974
13. Kim H, Hendrickson MR, Dorfman RF: Composite lymphoma. Cancer 40: 959–976, 1977
14. Cardinali G, Eusebi V: Hodgkin's disease and nodular lymphoma. Haematologica (Pavia) 60: 236–240, 1975
15. Mims CH, Costanzi JJ: Conversion of Hodgkin's disease to lymphoblastic lymphosarcoma. Oncology 29: 238–243, 1974
16. Carbone PP, Kaplan HS, Musshoff K, et al: Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 31: 1860–1861, 1971
17. Lukes RJ: Criteria for involvement of lymph node, bone marrow, spleen, and liver in Hodgkin's disease. Cancer Res 31: 1755–1767, 1971
18. Rappaport H: Tumors of the Hematopoietic System (Atlas of Tumor Pathology, Section 3, Fasc 8). Washington, DC, Armed Forces Institute of Pathology, 1966
19. Warnke R, Levy R: Immunopathology of follicular lymphomas: a model for B-lymphocyte homing. N Engl J Med 298: 481–486, 1978
20. Kaplan HS, Rosenberg SA: Current status of clinical trials: Stanford experience, 1962–74. Natl Cancer Inst Monogr 36: 363–371, 1973
21. Moore MR, Bull JM, Jones SE, et al: Sequential radiotherapy and chemotherapy in the treatment of Hodgkin's disease: a progress report. Ann Intern Med 77: 1–9, 1972
22. Rosenberg SA, Kaplan HS, Glatstein E, et al: The role of adjuvant MOPP in the radiation management of Hodgkin's disease: a progress report after eight years on the Stanford trials, Adjuvant Therapy of Cancer. Edited by SE Salmon, SE Jones. Amsterdam, Elsevier/North Holland, 1977, pp 505–515
23. Rosenberg SA, Kaplan HS, Glatstein E, et al: Combined modality therapy of Hodgkin's disease: a report of the Stanford trials. Cancer 42: 991–1000, 1978
24. Kaplan HS: Hodgkin's Disease. Cambridge, Massachusetts, Harvard University Press, 1972, pp 279–308
25. DeVita VT, Serpick AA, Carbone PP: Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 73: 881–895, 1970
26. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457–480, 1958
27. Coltman C Jr: Adriamycin (NSC-123127) in the treatment of lymphomas. Southwest Oncology Group Studies. Cancer Chemother Rep 6 (3):375–380, 1975
28. Schein PS, DeVita VT Jr, Hubbard S, et al: Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma. Ann Intern Med 85: 417–422, 1976
29. Lukes RJ, Collins RD: Immunologic characterization of human malignant lymphomas. Cancer 34: 1488–1503, 1974
30. Rosner F, Grünwald H: Hodgkin's disease and acute leukemia: report of eight cases and review of the literature. Am J Med 58: 339–353, 1975
31. Ibbotson RM, Revell PA, Molland FA, et al: The simultaneous presentation of Hodgkin's disease and myeloma. Postgrad Med J 53: 52–53, 1977
32. Sacks PV, Tavassoli M, Eastlund DT: Simultaneous occurrence of myeloma and Hodgkin's disease. Acta Haematol (Basel) 55: 118–122, 1976
33. Papaioannou A: Second malignancies in treated Hodgkin's patients and splenectomy. Lancet 1: 1346–1347, 1975
34. Berard C, O'Conor GT, Thomas LB, et al: Histopathological definition of Burkitt's tumor. Bull WHO 40: 601–607, 1969
35. Mann RB, Jaffe ES, Braylan RC, et al: Non-endemic Burkitt's lymphoma: a B-cell tumor related to germinal centers. N Engl J Med 295: 685–691, 1976
36. Matas AJ, Hertel BF, Rosai J, et al: Post-transplant malignant lymphoma: distinctive morphologic features related to its pathogenesis. Am J Med 61: 716–720, 1976
37. O'Conor GT: Persistent immunologic stimulation as a factor in oncogenesis, with special reference to Burkitt's tumor. Am J Med 48: 279–285, 1970
38. Purtilo DT, DeFlorio D Jr, Hutt LM, et al: Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome. N Engl J Med 297: 1077–1081, 1977
39. Purtilo DT: Opportunistic non-Hodgkin's lymphoma in X-linked recessive immunodeficiency and lymphoproliferative syndromes. Semin Oncol 4: 335–343, 1977